1. Home
  2. BMRN vs GME Comparison

BMRN vs GME Comparison

Compare BMRN & GME Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BMRN
  • GME
  • Stock Information
  • Founded
  • BMRN 1996
  • GME 1996
  • Country
  • BMRN United States
  • GME United States
  • Employees
  • BMRN N/A
  • GME N/A
  • Industry
  • BMRN Biotechnology: Pharmaceutical Preparations
  • GME Electronics Distribution
  • Sector
  • BMRN Health Care
  • GME Consumer Discretionary
  • Exchange
  • BMRN Nasdaq
  • GME Nasdaq
  • Market Cap
  • BMRN 11.3B
  • GME 10.2B
  • IPO Year
  • BMRN 1999
  • GME 2002
  • Fundamental
  • Price
  • BMRN $57.77
  • GME $22.60
  • Analyst Decision
  • BMRN Buy
  • GME Sell
  • Analyst Count
  • BMRN 23
  • GME 1
  • Target Price
  • BMRN $93.14
  • GME $13.50
  • AVG Volume (30 Days)
  • BMRN 1.8M
  • GME 5.8M
  • Earning Date
  • BMRN 10-28-2025
  • GME 09-09-2025
  • Dividend Yield
  • BMRN N/A
  • GME N/A
  • EPS Growth
  • BMRN 154.69
  • GME 494.62
  • EPS
  • BMRN 3.40
  • GME 0.47
  • Revenue
  • BMRN $3,063,608,000.00
  • GME $3,673,600,000.00
  • Revenue This Year
  • BMRN $13.32
  • GME N/A
  • Revenue Next Year
  • BMRN $9.37
  • GME N/A
  • P/E Ratio
  • BMRN $16.97
  • GME $47.89
  • Revenue Growth
  • BMRN 18.36
  • GME N/A
  • 52 Week Low
  • BMRN $52.93
  • GME $19.31
  • 52 Week High
  • BMRN $90.01
  • GME $35.81
  • Technical
  • Relative Strength Index (RSI)
  • BMRN 48.39
  • GME 47.01
  • Support Level
  • BMRN $55.99
  • GME $22.18
  • Resistance Level
  • BMRN $59.79
  • GME $23.73
  • Average True Range (ATR)
  • BMRN 1.37
  • GME 0.51
  • MACD
  • BMRN -0.05
  • GME 0.04
  • Stochastic Oscillator
  • BMRN 46.84
  • GME 26.77

About BMRN BioMarin Pharmaceutical Inc.

BioMarin is a global biotechnology company focused on developing and commercializing therapies for rare genetic diseases. BioMarin specializes in enzyme replacement therapies, gene therapies, and other advanced treatments aimed at addressing complex genetic disorders. The company has eight approved therapies for conditions including achondroplasia, phenylketonuria (PKU), hemophilia, and mucopolysaccharidosis. BioMarin has an expanding, yet relatively early-stage, pipeline of treatments in development.

About GME GameStop Corporation

GameStop Corp is a U.S. multichannel video game, consumer electronics, and services retailer. The company operates across Europe, Canada, Australia, and the United States. The company sells new and second-hand video game hardware, physical and digital video game software, and video game accessories, mainly through GameStop, EB Games, and Micromania stores and international e-commerce sites. The majority of sales are from the United States. The company categorizes its products in three categories: Hardware and accessories, Software, and Collectibles. The company generates the majority of its revenue from the sale of Hardware and accessories products.

Share on Social Networks: